CSL Plasma reached a significant milestone with the opening of its 200th collection center globally. This center is located in Jackson, Mississippi, a city known for helping to shape American history and culture.
The opening of the 200th center marks a period of significant growth for the global biotech leader.
"It is amazing to think that in a little over six years we have grown from 73 centers to 200 in the U.S., Germany and Hungary," said Mike Deem, Senior Vice President and General Manager for CSL Plasma. “As the demand for plasma grows, people are starting to understand the life-saving benefits, as it is the essential ingredient for products crucial to treating patients suffering from life-threatening conditions and disorders.”
Plasma is used to create therapies to treat conditions such as hemophilia, alpha-1 antitrypsin deficiency, and immune deficiencies, to name a few. It is also used to treat shock, burns and wounds. While access to donated plasma has increased with the expansion to meet global demand, processing and obtaining enough to treat those in need takes significant time and resources.
“Collecting enough plasma is critical to keeping our promise,” said Robert Mitchell, Director of Marketing and Corporate Communications, CSL Plasma. “We are committed to meeting the high demand for plasma, one location at a time.”
For more about plasma's role in helping people with rare diseases, check out the infographic below.